FR2425858A1 - Ophthalmic compsn. for treating ageing of the lens - contains glutamic acid, cysteine, glycine and fructose-1,6-di:phosphate - Google Patents

Ophthalmic compsn. for treating ageing of the lens - contains glutamic acid, cysteine, glycine and fructose-1,6-di:phosphate

Info

Publication number
FR2425858A1
FR2425858A1 FR7814854A FR7814854A FR2425858A1 FR 2425858 A1 FR2425858 A1 FR 2425858A1 FR 7814854 A FR7814854 A FR 7814854A FR 7814854 A FR7814854 A FR 7814854A FR 2425858 A1 FR2425858 A1 FR 2425858A1
Authority
FR
France
Prior art keywords
compsn
lens
esp
fructose
ophthalmic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7814854A
Other languages
French (fr)
Other versions
FR2425858B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Chauvin SAS
Original Assignee
Laboratoires Chauvin Blache SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Chauvin Blache SA filed Critical Laboratoires Chauvin Blache SA
Priority to FR7814854A priority Critical patent/FR2425858A1/en
Publication of FR2425858A1 publication Critical patent/FR2425858A1/en
Application granted granted Critical
Publication of FR2425858B1 publication Critical patent/FR2425858B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Opthalmic compsn. contains as active ingredients (A) a mixt. of the 3 amino acids which make up glutathione (Glu, Cys, Gly) and (B) D-fructose-1,6-diphosphate (I), opt. used as their inorganic or organic salts. Pref. the amino acids are present in the same mole ratio, 1:1:1, as in glutathione and the compsn. is esp. an aq. soln. contg. 0.01-5 (pref. 1-4) w/v% amino acids and 0.1-10 (pref. 5-10) w/v% (I), or their salts, Esp. (I) is used as its Na salt. Used esp. for treating ageing of the lens in human and veterinary medicine. The compsn. maintains the normal metabolic function of the lens, esp. a normal ATP level. There are no side effects or toxicity.
FR7814854A 1978-05-19 1978-05-19 Ophthalmic compsn. for treating ageing of the lens - contains glutamic acid, cysteine, glycine and fructose-1,6-di:phosphate Granted FR2425858A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7814854A FR2425858A1 (en) 1978-05-19 1978-05-19 Ophthalmic compsn. for treating ageing of the lens - contains glutamic acid, cysteine, glycine and fructose-1,6-di:phosphate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7814854A FR2425858A1 (en) 1978-05-19 1978-05-19 Ophthalmic compsn. for treating ageing of the lens - contains glutamic acid, cysteine, glycine and fructose-1,6-di:phosphate

Publications (2)

Publication Number Publication Date
FR2425858A1 true FR2425858A1 (en) 1979-12-14
FR2425858B1 FR2425858B1 (en) 1980-10-31

Family

ID=9208444

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7814854A Granted FR2425858A1 (en) 1978-05-19 1978-05-19 Ophthalmic compsn. for treating ageing of the lens - contains glutamic acid, cysteine, glycine and fructose-1,6-di:phosphate

Country Status (1)

Country Link
FR (1) FR2425858A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2849383A1 (en) * 2002-12-26 2004-07-02 Jean Noel Thorel TROPHIC COMPOSITION IN AQUEOUS MEDIUM, AND ITS APPLICATIONS, IN PARTICULAR IN OPHTHALMOLOGY

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2849383A1 (en) * 2002-12-26 2004-07-02 Jean Noel Thorel TROPHIC COMPOSITION IN AQUEOUS MEDIUM, AND ITS APPLICATIONS, IN PARTICULAR IN OPHTHALMOLOGY
WO2004060348A3 (en) * 2002-12-26 2004-09-23 Jean-Noel Thorel Ophthalmic and ophthalmological use of a complex nutritive base in an aqueous medium
US8435503B2 (en) 2002-12-26 2013-05-07 Jean-Noel Thorel Ophthalmic and ophthalmological use of a complex nutritive base in aqueous medium

Also Published As

Publication number Publication date
FR2425858B1 (en) 1980-10-31

Similar Documents

Publication Publication Date Title
ES8302453A1 (en) Dental remineralization composition
NO883073D0 (en) 3-DESMETHYL-MEVALONIC ACID DERIVATIVES, THE PROCEDURE FOR THEIR PREPARATION AND THEIR USE AS INTERMEDIATE PRODUCTS.
NO894740L (en) OFTALMIC SOLUTION, AND PROCEDURE FOR THE CONSERVATION OF SUCH SOLUTION.
IL84911A (en) Processes for the preparation of collagen products, and pharmaceutical compositions containing the same
DK485788A (en) COSMETIC PREPARATION
DK491284D0 (en) APPLICATION OF A HEAT STERILIZABLE Aqueous SOLUTION TO STORAGE RED BLOOD BODIES AND COMPOSED BLOOD POSITION SYSTEM CONTAINING A BAG WITH SUCH Aqueous SOLUTION
SE7904118L (en) WAY TO PREPARE A UROKINA COMPOSITION
AU1022588A (en) Ointment base and ointment
SE8303696D0 (en) PHARMACOLOGICAL COMPOSITIONS
DE3867445D1 (en) INJECTABLE SOLUTION OF THE THIOCTSEATE SALT WITH TROMETAMOL AND / OR BASIC AMINO ACIDS.
PT90362A (en) METHOD FOR THE TREATMENT OF MUCO-EPITHELIAL AND SKIN DISEASES IN MAMMALS USING ACID 4-KINOLINOCARBOXYLIC ACIDS AND ITS DERIVATIVES AND PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME COMPOUNDS
NO177500C (en) Process for the preparation of a therapeutically active hirudin variant
FR2425858A1 (en) Ophthalmic compsn. for treating ageing of the lens - contains glutamic acid, cysteine, glycine and fructose-1,6-di:phosphate
ES2043351T3 (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF HEPATIC DISEASES.
NO810480L (en) ANOLOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,3,4-OCSADIAZOLYLPHENOL DERIVATIVES
NO883520L (en) PROCEDURE FOR THE PREPARATION OF AN INJECTION PREPARATION.
AU7252581A (en) Salt of furosemide or piretanide as acid component and penbutolol or (-)-3-(4-3-(3,4-dimethoxyphenylethylamino)-2- hydroxypropoxy)-phenyl)-crotonitrile as base component
PT101007A (en) ICRF-187 lyophilized and stably prepared and its use and ICRF-187 lyophilized preparation process
ES2176222T3 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING HIRUDINE.
FR2597750B1 (en) STABLE AQUEOUS SOLUTION OF VINCRISTINE SULFATE
JPS5762218A (en) Ophthalmic solution
SE8803798L (en) PLASMINOGENPREPARAT
HUT42267A (en) Pesticide compositions containing 5,7-dihydro-6h-dibenz-/c,c/azepine-6-thio-carboximide-acid ester derivatives as active ingredients and process for preparing the active ingredients
DE68902223D1 (en) AQUEOUS SOLUTIONS OF DOXORUBICIN.
GB918754A (en) Improvements in or relating to corticotrophin preparations

Legal Events

Date Code Title Description
ST Notification of lapse